Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCHERVO
Stock Latest News
Private Companies
HERVolution Therapeutics Highlights Senescence-Based Platform Across Oncology and Metabolic Disease
10d ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Gains Scientific Momentum as HERV-K Data Extend Platform Beyond Oncology
2M ago
HERVO
Premium
Private Companies
Scientific Recognition of HERV-K Target Underscores Potential in Metabolic Disease
2M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Broadens HERV-K Platform With New Obesity and Inflammation Data
2M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Highlights HERV-K Data Linking Obesity, Inflammation and Aging
2M ago
HERVO
Premium
Private Companies
HERVolution Links HERV-K to Obesity-Driven Inflammation, Expanding Platform Beyond Oncology
2M ago
HERVO
Premium
Private Companies
HERVolution Showcases HERV-K Immunotherapy Research in Colorectal Cancer at ESMO GI 2026
3M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Expands HERV-K Platform Focus in Metabolic and Senescence-Driven Disease
3M ago
HERVO
Premium
Private Companies
HERVolution Highlights HERV-K Immunotherapy Strategy in Cardiometabolic Disease
3M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Highlights HERV-K Platform Research in Metabolic and Senescence-Driven Disease
3M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics – Weekly Recap
3M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Expands HERV Platform With Metabolic Disease Licensing Deal
3M ago
HERVO
Premium
Private Companies
HERVolution Secures Exclusive Obesity IP as Preclinical Data Validate HERV Platform in Metabolic Disease
3M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics – Weekly Recap
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Highlights HERV-Focused Strategy in Metabolic Disease
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Highlights HERV-Focused Approach in Metabolic Disease
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Sharpens Dark-Genome Strategy With HERV-Focused AI Platform and Inflammaging Insights
4M ago
HERVO
Premium
Private Companies
HERVolution Targets Dark Genome With HERV-Focused AI Discovery Platform
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Highlights AI-Driven HERV Discovery Platform
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Highlights HERV-Driven Inflammaging and Longevity-Focused Platform
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Emphasizes HERV Biology in Senescence and Inflammaging Strategy
4M ago
HERVO
Premium
Private Companies
HERVolution Therapeutics Bolsters Clinical Advisory Bench as IPT-001 Nears First-in-Human Trials
5M ago
HERVO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
